Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells

Biochemical and Biophysical Research Communications

Volumn 427, Issue 3, 2012, Pages 553-556

  Hirai, Toshiro ^a   Yoshioka, Yasuo ^a   Takahashi, Hideki ^a   Ichihashi, Ko ichi ^a   Yoshida, Tokuyuki ^a   Tochigi, Saeko ^a   Nagano, Kazuya ^b   Abe, Yasuhiro ^c   Kamada, Haruhiko ^a,b   Tsunoda, Shin ichi ^a,b   Nabeshi, Hiromi ^d   Yoshikawa, Tomoaki ^a   Tsutsumi, Yasuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c SANFORD RESEARCH   (United States)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

DCs; IL 2; Immune modulating effect; Nanoparticle; NMs; NSPs; NTiO2; OVA; Safety; Silica; SPs; SR

Indexed keywords

NANOPARTICLE; SILICONE;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOSOL; DENDRITIC CELL; IMMUNOMODULATION; IN VIVO STUDY; NANOANALYSIS; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REGULATORY MECHANISM; SURFACE PROPERTY; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; CROSS-PRIMING; DENDRITIC CELLS; MICE; MICE, INBRED C57BL; NANOPARTICLES; PARTICLE SIZE; SILICON DIOXIDE;

MURINAE;

EID: 84867843471     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.09.095     Document Type: Article

References (30)

1. Klein J. Probing the interactions of proteins and nanoparticles. Proc. Natl. Acad. Sci. USA 2007, 104:2029-2030.
2. Auffan M., Rose J., Bottero J.Y., Lowry G.V., Jolivet J.P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental health and safety perspective. Nat. Nanotechnol. 2009, 4:634-641.
3. Bowman D.M., van Calster G., Friedrichs S. Nanomaterials and regulation of cosmetics. Nat. Nanotechnol. 2010, 5:92.
4. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 2010, 7:653-664.
5. Peters R., Kramer E., Oomen A.G., Rivera Z.E., Oegema G., Tromp P.C., Fokkink R., Rietveld A., Marvin H.J., Weigel S., Peijnenburg A.A., Bouwmeester H. Presence of nano-sized silica during in vitro digestion of foods containing silica as a food additive. ACS Nano 2012, 6:2441-2451.
6. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69:8784-8789.
7. Yamashita K., Yoshioka Y., Higashisaka K., Mimura K., Morishita Y., Nozaki M., Yoshida T., Ogura T., Nabeshi H., Nagano K., Abe Y., Kamada H., Monobe Y., Imazawa T., Aoshima H., Shishido K., Kawai Y., Mayumi T., Tsunoda S., Itoh N., Yoshikawa T., Yanagihara I., Saito S., Tsutsumi Y. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 2011, 6:321-328.
8. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Kondoh M., Yagi K., Mayumi T., Tsunoda S., Tsutsumi Y. Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure. Nanotechnology 2012, 23:045101.
9. Napierska D., Thomassen L.C., Lison D., Martens J.A., Hoet P.H. The nanosilica hazard: another variable entity. Part. Fibre Toxicol. 2010, 7:39.
10. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Matsuo K., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Nakagawa S., Mayumi T., Tsunoda S., Tsutsumi Y. Systemic distribution nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials 2011, 32:2713-2724.
11. Hirai T., Yoshikawa T., Nabeshi H., Yoshida T., Akase T., Yoshioka Y., Itoh N., Tsutsumi Y. Dermal absorption of amorphous nanosilica particles after topical exposure for three days. Pharmazie 2012, 67:742-743.
12. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
13. Baker K., Qiao S.W., Kuo T.T., Aveson V.G., Platzer B., Andersen J.T., Sandlie I., Chen Z., de Haar C., Lencer W.I., Fiebiger E., Blumberg R.S. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc. Nat. Acad. Sci. USA 2011, 108:9927-9932.
14. Hirai T., Yoshikawa T., Nabeshi H., Yoshida T., Tochigi S., Uji M., Ichihashi K., Akase T., Yamashita T., Yamashita K., Nagano K., Abe Y., Kamada H., Tsunoda S., Yoshioka Y., Itoh N., Tsutsumi Y. Size-dependent immune-modulating effect of amorphous nanosilica particles. Pharmazie 2011, 66:727-728.
15. Hirai T., Yoshikawa T., Nabeshi H., Yoshida T., Tochigi S., Ichihashi K., Uji M., Akase T., Nagano K., Abe Y., Kamada H., Itoh N., Tsunoda S., Yoshioka Y., Tsutsumi Y. Amorphous silica nanoparticles size-dependently aggravate atopic dermatitis-like skin lesions following an intradermal injection. Part. Fibre Toxicol. 2012, 9:3.
16. Kurts C., Robinson B.W., Knolle P.A. Cross-priming in health and disease. Nat. Rev. Immunol. 2010, 10:403-414.
17. Zhou F., Huang L. Delivery of protein antigen to the major histocompatibility complex class I-restricted antigen presentation pathway. J. Drug Target. 1995, 3:91-109.
18. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu. Rev. Immunol. 1997, 15:821-850.
19. Nabeshi H., Yoshikawa T., Arimori A., Yoshida T., Tochigi S., Hirai T., Akase T., Nagano K., Abe Y., Kamada H., Tsunoda S., Itoh N., Yoshioka Y., Tsutsumi Y. Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res. Lett. 2011, 6:93.
20. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 1997, 158:2723-2730.
21. Pfeifer J.D., Wick M.J., Roberts R.L., Findlay K., Normark S.J., Harding C.V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 1993, 361:359-362.
22. Amigorena S., Savina A. Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr. Opin. Immunol. 2010, 22:109-117.
23. Joffre O.P., Segura E., Savina A., Amigorena S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 2012, 12:557-569.
24. Hamilton R.F., Thakur S.A., Mayfair J.K., Holian A. MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J. Biol. Chem. 2006, 281:34218-34226.
25. Orr G.A., Chrisler W.B., Cassens K.J., Tan R., Tarasevich B.J., Markillie L.M., Zangar R.C., Thrall B.D. Cellular recognition and trafficking of amorphous silica nanoparticles by macrophage scavenger receptor A. Nanotoxicology 2011, 5:296-311.
26. Hauck T.S., Ghazani A.A., Chan W.C. Assessing the effect of surface chemistry on gold nanorod uptake toxicity and gene expression in mammalian cells. Small 2008, 4:153-159.
27. Yu T., Hubbard D., Ray A., Ghandehari H. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry porosity and surface characteristics. J. Control. Release 2012.
28. Febvay S., Marini D.M., Belcher A.M., Clapham D.E. Targeted cytosolic delivery of cell-impermeable compounds by nanoparticle-mediated light-triggered endosome disruption. Nano Lett. 2010, 10:2211-2219.
29. Krpetic Z., Nativo P., See V., Prior I.A., Brust M., Volk M. Inflicting controlled nonthermal damage to subcellular structures by laser-activated gold nanoparticles. Nano Lett. 2010, 10:4549-4554.
30. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Tochigi S., Kondoh S., Hirai T., Akase T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Itoh N., Tsunoda S., Tsutsumi Y. Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part. Fibre Toxicol. 2011, 8:1.